Imipenem versus moxalactam in the treatment of serious infections.
Imipenem (formerly imipemide, N-formimidoyl thienamycin, or MK0787) was compared to moxalactam in a randomized therapeutic trial involving 39 evaluable patients with serious bacterial infections. Of those treated with imipenem, 89% were cured or improved versus 60% for moxalactam (P = 0.06). Althoug...
Kaydedildi:
| Yayımlandı: | Antimicrob Agents Chemother |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
American Society for Microbiology (ASM)
1983
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC185393/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6581755/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.24.6.841 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|